<DOC>
	<DOCNO>NCT01107106</DOCNO>
	<brief_summary>The purpose observational study ass safety tolerability ellaOne® routine condition use emergency contraception postmenarcheal adolescent adult woman want prevent pregnancy 5 day unprotected sexual intercourse .</brief_summary>
	<brief_title>Safety , Tolerability , Efficacy ellaOne® ( Ulipristal Acetate ) Emergency Contraception Postmenarcheal Adolescent Girls Women</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<criteria>Having receive ellaOne® emergency contraception clinical site Postmenarcheal adolescent adult woman Willing provide information bleeding , sexual intercourse , method contraception , concomitant medication adverse event next two menstrual period complete diary accordingly Willing provide information pregnancy outcome / delivery newborn 's health delivery Able provide write informed consent Willing participate clinical trial end study participation Currently participate interventional clinical trial ( test Investigational Medicinal Product )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Contraceptive Methods</keyword>
	<keyword>Female Contraception</keyword>
</DOC>